Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Abigail E. Case
Effects of the Multi‐kinase Inhibitor Midostaurin in Combination With Chemotherapy in Models of Acute Myeloid Leukaemia
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Related publications
Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia
Annals of Hematology
Medicine
Hematology
Stochastic Modelling of Tyrosine Kinase Inhibitor Rotation Therapy in Chronic Myeloid Leukaemia
BMC Cancer
Cancer Research
Oncology
Genetics
A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3
Haematologica
Hematology
Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cognitive Dysfunction After Withdrawal of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia
American Journal of Hematology
Hematology
Prognosis in Acute Myeloid Leukaemia.
BMJ
Razoxane in Treatment of Acute Myeloid Leukaemia.
BMJ
Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor
Cureus
Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
